Literature DB >> 12100966

Glyproline peptide family: review on bioactivity and possible origins.

G Samonina1, I Ashmarin, L Lyapina.   

Abstract

Glyproline peptide family includes the simplest proline-containing linear peptides PG, GP, PGP, respective peptides with hydroxylated proline residues and (with some restriction) cyclic PG. Having close structural resemblance they display many similar bioactivities. The suppression of some reactions of blood coagulation and platelet aggregation and protection of gastric mucosa against various ulcerogenic factors are the most important glyproline effects. Glyprolines have two common putative sources: (1) collagen and elastin synthesis and catabolism, and (2) penetration of proline-containing di- and tripeptides from food protein hydrolysate from the intestine into bloodstream. Possible physiological and biochemical mechanisms of glyproline bioactivities are under discussion.

Entities:  

Year:  2002        PMID: 12100966     DOI: 10.1016/s0928-4680(02)00018-4

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  4 in total

1.  Correlation analysis of cytokine gene expression changes and antiulcer effects of Pro-Gly-Pro and N-Acetyl-Pro-Gly-Pro in experimental models of ulceration.

Authors:  Z V Bakaeva; I G Kozlov; A D Sangadzhieva; G E Samonina; M V Mezentseva; L A Andreeva; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2016-01-05       Impact factor: 0.788

2.  Effects of glyprolines on stress-induced behavioral disorders in rats.

Authors:  S E Badmaeva; G N Kopylova; N N Abushinova; G E Samonina; B A Umarova
Journal:  Neurosci Behav Physiol       Date:  2006-05

Review 3.  IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.

Authors:  Jian Guan; Peter D Gluckman
Journal:  Br J Pharmacol       Date:  2009-05-11       Impact factor: 8.739

4.  A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats.

Authors:  R V M Krishnamurthi; S Mathai; A H Kim; R Zhang; J Guan
Journal:  Br J Pharmacol       Date:  2009-01-16       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.